Skip to main content

JAMA Internal Medicine Archives

Effective medications for opioid use disorder rarely used

Aug. 7, 2023—Vanderbilt research shows that most individuals diagnosed with opioid use disorder are not on recommended medications and even fewer remain in care.

Read more


More U.S. prostate cancer patients choosing active surveillance

Apr. 3, 2023—A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers.

Read more


Study evaluates polygenic risk score for prostate cancer risk prediction

Mar. 16, 2023—A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.

Read more


VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people

Feb. 6, 2023—Vanderbilt University Medical Center's ‘Shed-MEDS’ protocol may reduce risk drug-drug interactions in older peole.

Read more


Smokers have better quit rates with hospital-based interventions than quitline help, but study indicates need for longer follow-up

Jun. 28, 2022—A health care system model that offered tobacco cessation treatment to smokers being discharged from a hospital produced a higher rate of tobacco abstinence during the three-month program than referral to a state-based telephone quitline, but the advantage disappeared at six months when both treatments produced comparable quit rates, researchers have found.

Read more


Gene variants increase risk of kidney failure in veterans of African ancestry with COVID-19: study

Feb. 10, 2022—Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, possibly explaining some health disparities associated with COVID-19.

Read more


Two VUMC papers named among genomic medicine’s top 10

Dec. 16, 2021—Vanderbilt researchers wrote two of the “top 10” papers representing key advances in genomic medicine published between September 2020 and August 2021.

Read more


Allergic reaction to first dose of an mRNA COVID-19 vaccine should not keep people from getting the second dose: study

Jul. 26, 2021—An immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine — those manufactured by Moderna and Pfizer BioNTech — should not keep people from getting the second dose, a multi-hospital analysis shows.

Read more


Protein levels in urine after acute kidney injury predict future loss of kidney function

Jan. 28, 2020—High levels of protein in a patient’s urine after acute kidney injury is associated with increased risk of kidney disease progression, Vanderbilt researchers report.

Read more


Large-Scale Study Finds Higher Rates of Severe Psychological Distress and Impaired Physical Health among LGBT Populations

Jun. 27, 2016—In one of the largest, most representative health surveys conducted to date, lesbian, gay and bisexual adults reported substantially higher rates of severe psychological distress, heavy drinking and smoking, and impaired physical health than did heterosexuals.

Read more


VU study finds peanut consumption associated with decreased total mortality and mortality from cardiovascular diseases

Mar. 2, 2015—If you’re looking for a simple way to lower your risk of dying from a heart attack, consider going nuts.

Read more


Vanderbilt study finds use of methadone to treat pain carries increased risk of death

Jan. 20, 2015—Outside the hospital, use of methadone to treat pain carries a 46 percent increased risk of death when compared to the equally effective but more costly alternative, morphine SR (sustained release).

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more